Galectin-3在评估冠状动脉疾病后心肌梗死发生和预后中的价值(4)
[12] Desmedt V，Desmedt S，Delanghe J R，et al.Galectin-3 in Renal Pathology： More Than Just an Innocent Bystander[J].Am J Nephrol，2016，43(5)：305-317.
[13] Lepojarvi E S，Piira O P，P?kk? E，et al.Serum PINP， PIIINP， galectin-3， and ST2 as surrogates of myocardial fibrosis and echocardiographic left venticular diastolic filling properties[J].Front Physiol，2015，6：200.
[14] Jansen H，Koenig W，Jaensch A，et al.Prognostic Utility of Galectin-3 for recurrent cardiovascular events during Long-term follow-up in patients with stable coronary heart disease： Results of the KAROLA study[J].Clin Chem，2016，62：1372-1379.
[15] Zhang M，Meng Q，Qi X，et al.Comparison of multiple biomarkers for mortality prediction in patients with acute heart failure of ischemic and nonischemic etiology[J].Biomark Med，2018，12(11)：1207-1217.
[16] Perea R J，Morales-Ruiz M，Ortiz-Perez J T，et al.Utility of galectin-3 in predicting post-infarct remodeling after acute myocardial infarction based on extracellular volume fraction mapping[J].Int J Cardiol，2016，223：458-464.
(收稿日期：2019-11-21) (本文編辑：马竹君), 百拇医药(罗润发)
[13] Lepojarvi E S，Piira O P，P?kk? E，et al.Serum PINP， PIIINP， galectin-3， and ST2 as surrogates of myocardial fibrosis and echocardiographic left venticular diastolic filling properties[J].Front Physiol，2015，6：200.
[14] Jansen H，Koenig W，Jaensch A，et al.Prognostic Utility of Galectin-3 for recurrent cardiovascular events during Long-term follow-up in patients with stable coronary heart disease： Results of the KAROLA study[J].Clin Chem，2016，62：1372-1379.
[15] Zhang M，Meng Q，Qi X，et al.Comparison of multiple biomarkers for mortality prediction in patients with acute heart failure of ischemic and nonischemic etiology[J].Biomark Med，2018，12(11)：1207-1217.
[16] Perea R J，Morales-Ruiz M，Ortiz-Perez J T，et al.Utility of galectin-3 in predicting post-infarct remodeling after acute myocardial infarction based on extracellular volume fraction mapping[J].Int J Cardiol，2016，223：458-464.
(收稿日期：2019-11-21) (本文編辑：马竹君), 百拇医药(罗润发)